Repositioning of a Novel GABA-B Receptor Agonist, AZD3355 (Lesogaberan), for the Treatment of Non-alcoholic Steatohepatitis
Dipankar Bhattacharya(Ashoka University), Scott L. Friedman(Icahn School of Medicine at Mount Sinai)
Cited by 0
Related Papers
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
|Journal of Biological Chemistry|2000|2.1k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k
Focal Gains of <i>VEGFA</i> and Molecular Classification of Hepatocellular Carcinoma
|Cancer Research|2008|712